L.J. Altfest & Co
FBT icon

L.J. Altfest & Co’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

L.J. Altfest & Co’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,209
Closed -$5.02M – 339
2024
Q4 		$5.02M Buy
+30,209
New +$5.16M 0.64% 34

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Berger Financial Group
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return
Stonebridge Financial Group (Pennsylvania)
Stonebridge Financial Group (Pennsylvania) Wormleysburg, Pennsylvania $1.36B AUM 14.31% 1-Year Est. Return

L.J. Altfest & Co's FBT Position: Q1 2025 in Review

L.J. Altfest & Co sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2025, closing a stake of 30,209 shares — an estimated $5.02M sold.

L.J. Altfest & Co first reported a position in FBT in Q4 2024 and held it in 1 quarter. The position peaked at $5.02M in Q4 2024. 271 funds tracked by Wall St. Rank hold FBT as of Q1 2025.

  • L.J. Altfest & Co reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2025 after selling out during the quarter.
  • L.J. Altfest & Co sold 30,209 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2025, an estimated $5.02M.
  • L.J. Altfest & Co first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and held it in 1 quarter.
  • L.J. Altfest & Co's First Trust NYSE Arca Biotechnology Index Fund position peaked at $5.02M in Q4 2024.
  • 271 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2025.

Based on L.J. Altfest & Co's 13F filing for Q1 2025, filed 9 May 2025.